plasma testing for nsclc egfr & alk mutations
Published 6 years ago • 541 plays • Length 4:09Download video MP4
Download video MP3
Similar videos
-
9:30
egfr testing for nsclc
-
1:06
dr. goldman on targeted therapy options for egfr-, alk-, and ros1-mutated nsclc
-
7:31
mutation testing to guide alk tki selection in nsclc
-
8:25
egfr & alk/ros1 testing in squamous nsclc
-
9:23
mutation testing for all patients with nsclc
-
2:05
assess trial: blood test for egfr mutation in advanced non-small cell lung cancer
-
2:22
dr. ramalingam on plasma egfr mutations as a predictor of response in nsclc
-
1:01:27
molecular testing for egfr mutations: what pathologists need to know
-
3:36
testing and recommendations: egfr-mutated stage iv nsclc
-
7:07
mutation testing in nsclc
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc
-
5:06
role for plasma-based testing in lung cancer
-
3:57
mutation testing for nsclc in 2017
-
5:55
surgery options for nsclc & i-o therapy in egfr-mutations
-
6:09
mutation testing for nsclc
-
2:20
dr. kim discusses detecting egfr and kras mutations from cell-free plasma dna of nsclc patients
-
1:00
uncommon egfr mutations in metastatic non-small cell lung cancer.
-
4:27
molecular testing beyond egfr and alk in stage iv nsclc
-
2:51
targeting egfr and alk mutations